Urolithin A vs MitoQ: Two Approaches to Mitochondrial Health
MitoQ and urolithin A both target the mitochondria, but they do very different jobs. MitoQ is a mitochondria-targeted antioxidant designed to neutralize reactive oxygen species inside the organelle. Urolithin A supports mitophagy, the cell's process of clearing out and renewing worn mitochondria. Here is how the two approaches compare, with the evidence kept honest.
Same neighborhood, different jobs
It is easy to lump any supplement with the word mitochondria on the label into one bucket, but MitoQ and urolithin A represent two distinct strategies for keeping your cellular power plants healthy. One tries to protect existing mitochondria from oxidative wear. The other tries to help the cell replace the mitochondria that are already too worn to protect. Thinking of them as protection versus renewal is the cleanest way to keep them straight.
What MitoQ is
MitoQ is a branded form of mitoquinol (also written mitoquinone) mesylate. Chemically, it is a derivative of coenzyme Q10, the antioxidant your cells already use in energy production. What makes MitoQ different from ordinary CoQ10 is a lipophilic triphenylphosphonium (TPP+) cation attached to the molecule. That positive charge lets the compound accumulate inside the negatively charged interior of the mitochondria, where much of the cell's reactive oxygen species are generated. In other words, MitoQ is engineered to deliver antioxidant capacity to the exact location where oxidative stress originates, rather than diffusing it broadly through the body as standard CoQ10 tends to do. Its mechanism is fundamentally about quenching free radicals at the source.
MitoQ is sold as a consumer supplement and has been studied in various contexts, though as with much of this category, human clinical evidence is a mix of promising signals and areas still under investigation. We do not state MitoQ's price or dose here because they are not verified in this article; check the current label for those specifics.
What urolithin A is
Urolithin A comes from a completely different place, both literally and mechanistically. It is a gut postbiotic, a compound your intestinal bacteria produce from ellagitannins found in pomegranates, walnuts, and some berries. Only some people carry the microbes to make useful amounts, which is why a standardized supplement matters. Rather than acting as an antioxidant, urolithin A supports mitophagy, the quality-control pathway that tags damaged mitochondria and recycles them so the cell can build fresh ones. It addresses the population of mitochondria over time rather than shielding any single organelle from oxidative damage in the moment. Our urolithin A guide covers the full mechanism, and our page on mitochondrial health explains why renewal matters as we age.
The evidence, labeled honestly
Because this article compares two products, it is worth being precise about what has actually been shown in humans versus animals for urolithin A. (We are not making equivalent evidence claims for MitoQ, whose literature we have not detailed here.)
Proven in people
The first-in-human study, Andreux and colleagues in Nature Metabolism (2019), found urolithin A safe and well tolerated up to 1,000 mg per day and documented a mitochondrial gene-expression signature. Liu, D'Amico and colleagues (JAMA Network Open, 2022) reported improved muscle endurance in older adults over about four months. Singh and colleagues (Cell Reports Medicine, 2022) tested 500 mg and 1,000 mg in middle-aged adults over four months and saw gains in muscle strength and exercise performance.
Newer human findings
A 2024 randomized trial in the Journal of the International Society of Sports Nutrition studied resistance-trained men over eight weeks. A 2025 Nature Aging trial found that a roughly 28-day course supported the mitochondrial health of immune cells in midlife adults, relevant to inflammaging. A 2025 trial in distance runners rounds out the recent exercise literature. The muscle and cellular-energy outcomes remain the best-supported in humans.
Preclinical and early research
Ryu and colleagues (Nature Medicine, 2016) demonstrated mitophagy, extended lifespan in C. elegans, and improved rodent muscle. D'Amico and colleagues (Aging Cell, 2022) examined joint and cartilage outcomes in osteoarthritis models. These are animal and cell findings, not human proof. Skin, gut, brain, and heart applications are still early and exploratory. A 2024 systematic review in Ageing Research Reviews concluded that the human evidence for targeting aging with urolithin A is still emerging. See our clinical studies summary for more.
Protection versus renewal: how to think about it
Different targets, not direct rivals
An antioxidant approach like MitoQ aims to reduce oxidative damage to mitochondria that already exist. A mitophagy approach like urolithin A aims to help the cell retire mitochondria that are beyond saving and replace them. These are complementary ideas in principle. Neither one makes the other unnecessary, and they are not measuring the same outcome.
Evidence specificity
Urolithin A's human trials point to concrete, measurable endpoints, particularly muscle endurance and strength. When comparing any two supplements, ask what has been demonstrated in people, at what dose, and over what duration, rather than accepting mechanism alone as proof.
Form and routine
The two products differ in how you take them, and daily adherence over weeks to months is what the urolithin A studies required to show benefit. A once-daily gummy is easy to keep consistent. For timing tips, see how to take urolithin A.
Antioxidant caveat
More antioxidant is not always better. Some exercise adaptations depend on transient oxidative signaling, and blunting it indiscriminately is an area of ongoing research. This is a nuance worth discussing with a clinician if you train seriously.
Practical guidance
If your interest is specifically in quenching mitochondrial free radicals, a targeted antioxidant is the category built for that idea; verify its current label and study base yourself. If you are drawn to the renewal side of the equation, urolithin A has an unusually specific human evidence base for a longevity-adjacent compound, anchored to a clear studied dose. Some people are curious about combining the two; there is no strong human trial data on that pairing, so treat it as experimental and run it past your provider. When comparing finished urolithin A products, our roundup of the best urolithin A gummies explains what belongs on a good label.
For transparency: SOMA HEALTH is a competitor to MitoQ, so weigh our framing with that in mind and confirm any competitor's specifics on their current label. Urolithin A supports normal mitochondrial and cellular function; it is not a treatment for any disease or age-related condition and is not a substitute for medical care. If you have a specific health concern, see your doctor.
Frequently asked questions
Is MitoQ the same as CoQ10?
MitoQ is a modified form of CoQ10 with a triphenylphosphonium group added so it accumulates inside mitochondria. It is designed as a mitochondria-targeted antioxidant rather than ordinary dietary CoQ10.
Does urolithin A work as an antioxidant like MitoQ?
Not primarily. Its main studied role is supporting mitophagy, the renewal of worn mitochondria, which is a different mechanism from directly neutralizing free radicals.
Can I take MitoQ and urolithin A together?
Their mechanisms differ, so some people are curious about combining them, but there is no strong human trial evidence on the pairing. Discuss it with a healthcare provider before stacking supplements.
Which has stronger human evidence?
We have detailed urolithin A's human trials here, which point to muscle endurance and strength at 500 to 1,000 mg per day. We have not detailed MitoQ's literature, so compare its current label and published studies directly rather than taking a claim on faith.
What dose of urolithin A is studied?
Human trials used 500 to 1,000 mg per day, with 1,000 mg at the top. SOMA HEALTH Urolithin A Gummies provide 1,000 mg per daily serving; see our dosage guide.
How long until I might notice a difference with urolithin A?
The trials ran roughly four to sixteen weeks. Consistent daily use over months reflects how the benefits were measured.
Is a targeted antioxidant safer than urolithin A?
Both are sold as supplements with their own safety profiles. Urolithin A was well tolerated up to 1,000 mg per day in trials. Review either product with your clinician, especially if you take medications.
*These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease. This guide is educational and is not a substitute for advice from a qualified healthcare provider.
A clinically studied 1,000 mg dose of Urolithin A in one simple daily gummy — to support mitophagy, muscle strength, and cellular energy.
Shop SOMA Urolithin A Gummies →